KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 153 filers reported holding KRYSTAL BIOTECH INC in Q3 2022. The put-call ratio across all filers is 3.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,017,519 | +46.6% | 17,185 | 0.0% | 1.52% | +41.3% |
| Q1 2023 | $1,375,831 | +1.1% | 17,185 | 0.0% | 1.07% | +4.5% |
| Q4 2022 | $1,361,396 | +13.6% | 17,185 | 0.0% | 1.03% | +0.4% |
| Q3 2022 | $1,198,000 | +6.2% | 17,185 | 0.0% | 1.02% | +12.8% |
| Q2 2022 | $1,128,000 | -1.3% | 17,185 | 0.0% | 0.91% | +18.7% |
| Q1 2022 | $1,143,000 | -4.9% | 17,185 | 0.0% | 0.76% | +0.3% |
| Q4 2021 | $1,202,000 | +32.5% | 17,185 | -1.1% | 0.76% | +14.1% |
| Q3 2021 | $907,000 | -22.8% | 17,376 | +0.6% | 0.67% | -22.7% |
| Q2 2021 | $1,175,000 | -11.3% | 17,277 | +0.5% | 0.86% | -18.2% |
| Q1 2021 | $1,324,000 | +25.5% | 17,192 | -2.2% | 1.06% | +16.6% |
| Q4 2020 | $1,055,000 | +29.8% | 17,586 | -6.9% | 0.91% | +23.8% |
| Q3 2020 | $813,000 | +13.1% | 18,894 | +8.8% | 0.73% | -7.3% |
| Q2 2020 | $719,000 | – | 17,369 | – | 0.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,896,645 | $150,252,217 | 6.15% |
| S Squared Technology, LLC | 108,215 | $8,572,792 | 5.80% |
| Frazier Life Sciences Management, L.P. | 999,737 | $79,199,165 | 4.92% |
| First Light Asset Management, LLC | 473,691 | $37,525,801 | 3.48% |
| Ikarian Capital, LLC | 165,900 | $13,142,598 | 3.17% |
| Soleus Capital Management, L.P. | 188,217 | $14,910,551 | 2.14% |
| Integral Health Asset Management, LLC | 115,000 | $9,110,300 | 1.91% |
| Nicholas Investment Partners, LP | 267,089 | $21,158,791 | 1.85% |
| Artal Group S.A. | 400,000 | $31,688 | 1.77% |
| Avoro Capital Advisors LLC | 1,410,000 | $111,700,200 | 1.67% |